Labcorp (LH) share buybacks: $450M
Labcorp spent $450M buying back its own shares in the year ended Dec 31, 2025, up 79.9% from $250M a year earlier.
From Labcorp's filings with the SEC · Read the filing · LH stock page
Labcorp share buybacks by year
#394 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $450M | +80% |
| Dec 31, 2024 | $250M | -75% |
| Dec 31, 2023 | $1B | -9% |
| Dec 31, 2022 | $1.1B | -34% |
| Dec 31, 2021 | $1.7B | – |
Share buybacks of similar companies
Companies in the same industry as Labcorp, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Davita | $1.3B | Dec 31, 2025 |
| Universal Health Services | $968M | Dec 31, 2025 |
| Labcorp | $450M | Dec 31, 2025 |
| Quest Diagnostics | $450M | Dec 31, 2025 |
| Chemed | $432M | Dec 31, 2025 |
| Option Care Health | $310M | Dec 31, 2025 |
| Encompass Health | $158M | Dec 31, 2025 |
Questions and answers
What is Labcorp's share buybacks?
Labcorp spent $450M buying back its own shares in the year ended Dec 31, 2025, up 79.9% from $250M a year earlier.
Numbers as reported in Labcorp's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology